Biotech Stocks: Amgen Rallies to New Highs
The biotech industry is one of the most closely watched sectors in the stock market, and the first quarter of 2017 has been no exception to this rule. All of the media discussion about President Trump’s repeal and replacement of Obamacare led many to believe the healthcare sector would see a major sell-off. But when […]